Edition:
United Kingdom

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

109.00SEK
23 May 2018
Change (% chg)

-1.80kr (-1.62%)
Prev Close
110.80kr
Open
111.40kr
Day's High
112.00kr
Day's Low
108.00kr
Volume
13,205
Avg. Vol
36,402
52-wk High
112.00kr
52-wk Low
82.00kr

Chart for

About

Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO... (more)

Overall

Beta: 0.44
Market Cap(Mil.): kr2,461.91
Shares Outstanding(Mil.): 26.19
Dividend: --
Yield (%): --

Financials

  XVIVO.ST Industry Sector
P/E (TTM): -- 32.19 32.75
EPS (TTM): -0.01 -- --
ROI: -0.02 13.89 14.38
ROE: -0.02 16.72 16.07

BRIEF-Xvivo Perfusion Q1 Adjusted. EBITDA Sek 7.2 Million

* Q1 ADJUSTED. EBITDA SEK 7.2 MILLION VERSUS SEK 5.0 MILLION YEAR AGO

26 Apr 2018

BRIEF-Xvivo Perfusion AB Net Sales Of Non-Durable Goods In Q4 Amounted To Sek 39.4 (34.6) Million

* NET SALES OF NON-DURABLE GOODS IN Q4 AMOUNTED TO SEK 39.4 (34.6) MILLION

09 Feb 2018

Earnings vs. Estimates